Wall Street analyst estimates for CorVel Corporation (CRVL): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims. The company focuses on controlling medical expenditures and ensuring high-quality care across various sectors, including workers' compensation, auto liability, and general health.
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-03 | |||
| 2026-08-05 | $0.63 | ||
| 2026-05-20 | $0.61 | ||
| 2026-02-03 | $0.47 | ||
| 2025-11-04 | $0.54 | ||
| 2025-08-05 | $0.52 | ||
| 2025-05-22 | $0.51 | ||
| 2025-02-04 | $0.46 |
Valuation Ratios
| P/E Ratio | 33.54 |
| Price / Book | 9.38 |
| EV / EBITDA | 19.70 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $518.7M | $558.4M | $595.7M | $592.2M | $552.6M | $646.2M | $718.6M | $795.3M | $895.6M | $958.5M |
| Cost of Revenue | $413.9M | $451.1M | $470.9M | $466.3M | $429.0M | $494.1M | $560.3M | $623.6M | $685.9M | $725.7M |
| Gross Profit | $104.8M | $107.3M | $124.8M | $125.9M | $123.6M | $152.1M | $158.3M | $171.7M | $209.7M | $232.9M |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $57.2M | $59.4M | $63.3M | $65.2M | $64.4M | $67.6M | $73.7M | $76.6M | $88.9M | $89.73B |
| Operating Expenses | $57.2M | $59.4M | $63.3M | $65.2M | $64.4M | $67.6M | $73.7M | $76.6M | $88.9M | $89.7M |
| Operating Income | $47.5M | $47.9M | $61.5M | $60.7M | $59.2M | $84.5M | $84.6M | $95.1M | $120.8M | $143.1M |
| EBITDA | $68.5M | $69.7M | $84.5M | $83.2M | $82.6M | $108.4M | $109.7M | $121.4M | $150.4M | $174.9M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-tax Income | $47.5M | $47.9M | $61.5M | $60.7M | $59.2M | $84.5M | $84.6M | $95.1M | $120.8M | $143.1M |
| Income Tax | $18.1M | $12.2M | $14.8M | $13.3M | $12.8M | $18.1M | $18.2M | $18.8M | $25.7M | $32.8M |
| Net Income | $29.5M | $35.7M | $46.7M | $47.4M | $46.4M | $66.4M | $66.4M | $76.3M | $95.2M | $110.3M |
| EPS | $1.51 | $1.87 | $2.46 | $2.56 | $2.50 | $1.25 | $1.28 | $1.48 | $1.85 | $2.15 |
| EPS (Diluted) | $1.51 | $1.87 | $2.46 | $2.56 | $2.50 | $1.22 | $1.26 | $1.47 | $1.83 | $2.14 |
| Shares Outstanding (Diluted) | $19.6M | $19.0M | $19.0M | $18.5M | $18.5M | $54.4M | $52.8M | $52.0M | $52.0M | $51.6M |
Price
| Price | $76.00 |
| Market Cap | $3.9B |
| Exchange | NASDAQ |
| Country | US |
Related companies: AGO · ATH · CNO · FG · FHI · GBDC · GNW
Explore sector: Financial Services · Insurance - Brokers
More sections of CRVL: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks